| Circular RNAs in diseases | Lifetime | 48 | CN 23 | 99.42 |
| MicroRNA in disease regulation | Lifetime | 254 | CN 87 | 99.00 |
| Inflammasome and immune disorders | Lifetime | 79 | CN 5 | 98.87 |
| Cancer-related molecular mechanisms research | Lifetime | 428 | CN 194 | 98.60 |
| Circadian rhythm and melatonin | Lifetime | 334 | CN 4 | 97.74 |
| Genomics, phytochemicals, and oxidative stress | Lifetime | 268 | CN 17 | 97.37 |
| Cardiac Ischemia and Reperfusion | Lifetime | 452 | CN 24 | 97.26 |
| Sirtuins and Resveratrol in Medicine | Lifetime | 210 | CN 31 | 95.52 |
| Heme Oxygenase-1 and Carbon Monoxide | Lifetime | 361 | CN 15 | 96.14 |
| Biomarkers in Disease Mechanisms | Lifetime | 238 | CN 11 | 92.02 |
| FOXO transcription factor regulation | Lifetime | 149 | CN 16 | 92.88 |
| Gout, Hyperuricemia, Uric Acid | Lifetime | 769 | CN 92 | 88.81 |
| Apelin-related biomedical research | Lifetime | 877 | CN 77 | 84.46 |
| Silymarin and Mushroom Poisoning | Lifetime | 389 | CN 31 | 76.30 |
| Mechanisms of cancer metastasis | Lifetime | 452 | CN 80 | 74.45 |
| Circular RNAs in diseases | 2021-2025 | 8 | CN 4 | 99.68 |
| MicroRNA in disease regulation | 2021-2025 | 22 | CN 13 | 99.56 |
| Biomarkers in Disease Mechanisms | 2021-2025 | 2 | CN 1 | 96.76 |
| Cancer-related molecular mechanisms research | 2021-2025 | 66 | CN 43 | 99.30 |
| Inflammasome and immune disorders | 2021-2025 | 16 | CN 7 | 98.82 |
| Neuroinflammation and Neurodegeneration Mechanisms | 2021-2025 | 56 | CN 17 | 98.41 |
| Circadian rhythm and melatonin | 2021-2025 | 27 | CN 2 | 97.94 |
| Phagocytosis and Immune Regulation | 2021-2025 | 51 | CN 19 | 92.45 |
| Heme Oxygenase-1 and Carbon Monoxide | 2021-2025 | 110 | CN 43 | 88.01 |
| Peroxisome Proliferator-Activated Receptors | 2021-2025 | 125 | CN 36 | 85.64 |
| Gout, Hyperuricemia, Uric Acid | 2021-2025 | 158 | CN 58 | 88.18 |
| Cardiac Ischemia and Reperfusion | 2021-2025 | 138 | CN 37 | 86.85 |
| Immune Response and Inflammation | 2021-2025 | 400 | CN 167 | 84.75 |
| Apelin-related biomedical research | 2021-2025 | 55 | CN 9 | 83.25 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | 2021-2025 | 976 | CN 152 | 87.26 |
| Chemokine receptors and signaling | 2021-2025 | 130 | CN 16 | 81.69 |
| Acute Kidney Injury Research | 2021-2025 | 616 | CN 168 | 81.50 |
| Cytokine Signaling Pathways and Interactions | 2021-2025 | 508 | CN 150 | 75.48 |
| Galectins and Cancer Biology | 2021-2025 | 439 | CN 108 | 76.12 |
| Advanced Glycation End Products research | 2021-2025 | 397 | CN 168 | 74.76 |
| Eicosanoids and Hypertension Pharmacology | 2021-2025 | 335 | CN 62 | 74.00 |
| Genetics, Aging, and Longevity in Model Organisms | 2021-2025 | 722 | CN 119 | 74.55 |
| Signaling Pathways in Disease | 2021-2025 | 451 | CN 183 | 61.82 |
| Calcium signaling and nucleotide metabolism | 2021-2025 | 711 | CN 142 | 42.20 |
